1. Selling put options on Intel and CRISPR Therapeutics offers high returns with moderate risk; 2. Intel's $22 strike June 20th puts provide a 19.07% annualized yield; 3. CRISPR's $30 strike July 18th puts offer a 13.51% annualized yield.
Related Articles
- Supercharge Your Retirement With Income Machines Paying Fat Dividends3 months ago
- 5 Oversold Dividend Kings To Buy Today3 months ago
- Why And How To Plan For A Potential $2 Million Retirement3 months ago
- My Top 10 High-Yield Dividend Stocks For March 20253 months ago
- 5 Overlooked 12% Yields To Supercharge Your Early Retirement3 months ago
- Top 10 Beaten Down Tech Stocks For 20253 months ago
- Margin Balances Suggests Risks Are Building3 months ago
- Occidental Petroleum: 3 Reasons We Prefer The 7% YTM Bonds For Berkshire's Bet3 months ago
- These Big Dividends Are Printing Cash - I'm Going All In4 months ago
- High-Yield Dividend Kings: 1 To Buy, 1 To Avoid4 months ago